Literature DB >> 17486062

Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation.

B Zhang1, K J Chambers, D V Faller, S Wang.   

Abstract

The SWI/SNF complex participates as a co-activator in the transcriptional regulation of certain genes. Conversely, we and others have recently established that Brg1 and Brm, the central components of SWI/SNF, act instead as co-repressors for E2F-mediated transcriptional repression, and for the transcription of certain other promoters. We report here that Brg-1 and Brm can switch their mode of function at same promoter between activation and repression by ligand-directed differential coordination with BAF155, BAF170, HDAC1, p300 and prohibitin. This ligand and context-dependent reprogramming of the SWI/SNF complex allows it to differentially serve as either a co-repressor or a co-activator of transcription at the same promoter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486062     DOI: 10.1038/sj.onc.1210509

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Dynamic nature of transcriptional regulation of nuclear receptor target genes in the context of chromatin organization.

Authors:  Sami Väisänen; Juha Matilainen; Carsten Carlberg
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 2.  Basic concepts of epigenetics: impact of environmental signals on gene expression.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

Review 3.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

4.  A unique missense allele of BAF155, a core BAF chromatin remodeling complex protein, causes neural tube closure defects in mice.

Authors:  Laura Harmacek; Dawn E Watkins-Chow; Jianfu Chen; Kenneth L Jones; William J Pavan; J Michael Salbaum; Lee Niswander
Journal:  Dev Neurobiol       Date:  2014-01-09       Impact factor: 3.964

5.  Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats.

Authors:  Minji Choi; Harmesh N Chaudhari; Young Rae Ji; Zae Young Ryoo; Sang Woo Kim; Jong Won Yun
Journal:  Mol Cell Biochem       Date:  2015-06-06       Impact factor: 3.396

6.  Immunohistochemical expression and mutation study of Prohibitin gene in Indian female breast cancer cases.

Authors:  Mohammad Zeeshan Najm; Shuaib Zaidi; Waseem Ahmad Siddiqui; Syed Akhtar Husain
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

7.  Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.

Authors:  Fei Fang; Dewei Chen; Liming Yu; Xin Dai; Yuyu Yang; Wenfang Tian; Xian Cheng; Huihui Xu; Xinyu Weng; Mingming Fang; Jiliang Zhou; Yuqi Gao; Qi Chen; Yong Xu
Journal:  Circ Res       Date:  2013-08-20       Impact factor: 17.367

8.  Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives.

Authors:  Susan P Perrine; Rishikesh Mankidy; Michael S Boosalis; James J Bieker; Douglas V Faller
Journal:  Eur J Haematol       Date:  2009-02-05       Impact factor: 2.997

9.  Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.

Authors:  Yan Dai; Duyen Ngo; Johanna Jacob; Lora W Forman; Douglas V Faller
Journal:  Carcinogenesis       Date:  2008-05-16       Impact factor: 4.944

10.  HIC1 regulates tumor cell responses to endocrine therapies.

Authors:  Baohua Zhang; Douglas V Faller; Sheng Wang
Journal:  Mol Endocrinol       Date:  2009-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.